---
title: "Jacobio Pharmaceuticals files HKEX next-day disclosure return on share buyback"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290176209.md"
description: "Jacobio Pharmaceuticals filed a next-day disclosure return with the HKEX regarding a share buyback executed on June 18. The company repurchased 113,400 ordinary shares at a price range of HKD 4.38–4.42 per share, totaling HKD 498,624. All purchased shares were held as treasury shares and none were cancelled."
datetime: "2026-06-18T09:52:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290176209.md)
  - [en](https://longbridge.com/en/news/290176209.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290176209.md)
generator: "portal-rs"
---

# Jacobio Pharmaceuticals files HKEX next-day disclosure return on share buyback

-   Jacobio Pharmaceuticals repurchased 113,400 ordinary shares on June 18, holding all as treasury shares; none were cancelled. \* Buyback executed on HKEX at HKD 4.38–4.42 per share; total consideration HKD 498,624. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobio Pharmaceuticals Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260618-12208100), on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [01167.HK](https://longbridge.com/en/quote/01167.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Jacobio doses first patient in Phase IIa China trial of JAB-8263 for rheumatoid arthritis](https://longbridge.com/en/news/293854649.md)
- [Robo.ai COO Chaoyin Xie files initial beneficial ownership statement](https://longbridge.com/en/news/296381712.md)
- [Kuaishou files HKEX next-day disclosure return, share capital rises by 213,553 shares](https://longbridge.com/en/news/296482134.md)
- [Marshall Wace discloses net short position in Capital B shares](https://longbridge.com/en/news/296625312.md)
- [Higgsfield raises $400 million in Series B at $5.4 billion valuation, Intel Capital joins round](https://longbridge.com/en/news/296370991.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**